Key Takeaways
- The FDA is establishing a pilot program for split real time review of a small number of original NDAs and BLAs.
The US Food and Drug Administration is expanding the Split Real Time Application Review (STAR) approach beyond the confines of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?